Industry Insights Healthcare

Industry Insights: Healthcare 28th June

Industry Insights: Healthcare 28th June

  • Reading time:2 mins read

Industry Insights Healthcare: 28/06/24

Here are three briefly summarised articles to help keep you informed of the latest developments in the industry. 

Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity

Novo Nordisk has announced a $4.1 billion investment to construct a second fill and finishing manufacturing facility in Clayton, North Carolina. This facility will focus on procuring current and future injectable treatments for people with obesity and other serious chronic diseases. The new facility will add 1.4 million square feet of production space, doubling the combined square footage of all three of the company’s facilities in North Carolina. This announcement follows closely on the heels of Eli Lilly’s recent announcement it will invest USD $5.3 billion to increase its manufacturing capacity

Verona Pharma announces US FDA approval of Ohtuvavre™ (ensifentrine)

The US Food and Drug Administration (FDA) has approved Ohtuvayre for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. This is the first novel treatment in more than a decade for COPD. Ohtuvavre is a selective dual inhibitor of the phosphodiesterase 3 and phosphodiesterase 4 enzymes, approved as an add-on to current therapies. The FDA’s decision was based on the Phase 3 ENHANCE trial, which demonstrated clinical benefit both as monotherapy and with other maintenance therapies. Ohtuvayre is expected to be available in the third quarter 2024. 

American Cancer Society and American Society of Clinical Oncology to create one of the largest and most comprehensive online sources of credible cancer information 

The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) have announced a collaboration to streamline access to authoritative cancer sites, and, to cover the entire cancer continuum from prevention to survivorship. The goal is to ensure that individuals affected by cancer can easily find and access high-quality information. This information can now all be found on 

Check out our other Industry Insights on LinkedIn or learn more at

Elion Medical Communications